EBS

SEC source: 0001367644-24-000107 · wk-form4_1718136637.xml · nonDerivative · entry 1

Williams Paul Anthony · CIK 0001961994 · SVP, Products Business

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,418

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-24-000106 · wk-form4_1718136625.xml · nonDerivative · entry 1

Glessner Coleen · CIK 0001919170 · EVP, Quality & Ethics, and CPL

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 163,134

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-24-000104 · wk-form4_1718136603.xml · nonDerivative · entry 1

Hartzel William · CIK 0001989644 · SVP, Bioservices

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,107

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-24-000098 · wk-form4_1717704966.xml · nonDerivative · entry 1

Zoon Kathryn C · CIK 0001685720 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,482

SEC source: 0001367644-24-000095 · wk-form4_1717182155.xml · nonDerivative · entry 1

Zoon Kathryn C · CIK 0001685720 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,482

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a grandfathered trading plan adopted by Ms. Zoon on June 15, 2022.

SEC source: 0001367644-24-000077 · wk-form4_1716945262.xml · derivative · entry 2

Zoon Kathryn C · CIK 0001685720 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,748

Underlying: Common Stock · 25,748 shares

Expires 2031-05-22

F2 · derivative.exercise_date: Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price.

F3 · derivative.underlying_shares: The number of options granted was determined by dividing half of the total non-employee director compensation value by the Black-Scholes value of a single option calculated as of the date of the grant.

SEC source: 0001367644-24-000077 · wk-form4_1716945262.xml · nonDerivative · entry 1

Zoon Kathryn C · CIK 0001685720 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,312

F1 · shares: Represents an annual grant of restricted stock units ("RSUs") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the "Company") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date ("Annual Grant Vesting Date"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date.

SEC source: 0001367644-24-000088 · wk-form4_1716946866.xml · derivative · entry 2

Fowler Neal Franklin · CIK 0001493692 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,748

Underlying: Common Stock · 25,748 shares

Expires 2031-05-22

F2 · derivative.exercise_date: Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price.

F3 · derivative.underlying_shares: The number of options granted was determined by dividing half of the total non-employee director compensation value by the Black-Scholes value of a single option calculated as of the date of the grant.

SEC source: 0001367644-24-000088 · wk-form4_1716946866.xml · nonDerivative · entry 1

Fowler Neal Franklin · CIK 0001493692 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 136,100

F1 · shares: Represents an annual grant of restricted stock units ("RSUs") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the "Company") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date ("Annual Grant Vesting Date"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date.

SEC source: 0001367644-24-000086 · wk-form4_1716946839.xml · derivative · entry 2

White Marvin L · CIK 0001493324 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,748

Underlying: Common Stock · 25,748 shares

Expires 2031-05-22

F2 · derivative.exercise_date: Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price.

F3 · derivative.underlying_shares: The number of options granted was determined by dividing half of the total non-employee director compensation value by the Black-Scholes value of a single option calculated as of the date of the grant.

SEC source: 0001367644-24-000086 · wk-form4_1716946839.xml · nonDerivative · entry 1

White Marvin L · CIK 0001493324 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,379

F1 · shares: Represents an annual grant of restricted stock units ("RSUs") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the "Company") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date ("Annual Grant Vesting Date"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date.

SEC source: 0001367644-24-000079 · wk-form4_1716945287.xml · derivative · entry 2

SULLIVAN LOUIS W · CIK 0001193522 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,748

Underlying: Common Stock · 25,748 shares

Expires 2031-05-22

F2 · derivative.exercise_date: Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price.

F3 · derivative.underlying_shares: The number of options granted was determined by dividing half of the total non-employee director compensation value by the Black-Scholes value of a single option calculated as of the date of the grant.

SEC source: 0001367644-24-000079 · wk-form4_1716945287.xml · nonDerivative · entry 1

SULLIVAN LOUIS W · CIK 0001193522 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 104,695

F1 · shares: Represents an annual grant of restricted stock units ("RSUs") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the "Company") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date ("Annual Grant Vesting Date"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date.

SEC source: 0001367644-24-000089 · wk-form4_1716946880.xml · derivative · entry 2

Katkin Keith · CIK 0001314596 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,748

Underlying: Common Stock · 25,748 shares

Expires 2031-05-22

F2 · derivative.exercise_date: Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price.

F3 · derivative.underlying_shares: The number of options granted was determined by dividing half of the total non-employee director compensation value by the Black-Scholes value of a single option calculated as of the date of the grant.

SEC source: 0001367644-24-000089 · wk-form4_1716946880.xml · nonDerivative · entry 1

Katkin Keith · CIK 0001314596 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,872

F1 · shares: Represents an annual grant of restricted stock units ("RSUs") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the "Company") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date ("Annual Grant Vesting Date"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date.

SEC source: 0001367644-24-000087 · wk-form4_1716946853.xml · derivative · entry 2

DeGolyer Donald W · CIK 0001583098 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,748

Underlying: Common Stock · 25,748 shares

Expires 2031-05-22

F2 · derivative.exercise_date: Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price.

F3 · derivative.underlying_shares: The number of options granted was determined by dividing half of the total non-employee director compensation value by the Black-Scholes value of a single option calculated as of the date of the grant.

SEC source: 0001367644-24-000087 · wk-form4_1716946853.xml · nonDerivative · entry 1

DeGolyer Donald W · CIK 0001583098 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 136,100

F1 · shares: Represents an annual grant of restricted stock units ("RSUs") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the "Company") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date ("Annual Grant Vesting Date"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date.

SEC source: 0001367644-24-000085 · wk-form4_1716946827.xml · derivative · entry 2

Dayal Sujata Tyagi · CIK 0001536908 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,748

Underlying: Common Stock · 25,748 shares

Expires 2031-05-22

F2 · derivative.exercise_date: Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price.

F3 · derivative.underlying_shares: The number of options granted was determined by dividing half of the total non-employee director compensation value by the Black-Scholes value of a single option calculated as of the date of the grant.

SEC source: 0001367644-24-000085 · wk-form4_1716946827.xml · nonDerivative · entry 1

Dayal Sujata Tyagi · CIK 0001536908 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,129

F1 · shares: Represents an annual grant of restricted stock units ("RSUs") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the "Company") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date ("Annual Grant Vesting Date"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date.

SEC source: 0001367644-24-000078 · wk-form4_1716945275.xml · derivative · entry 2

Harsanyi Zsolt · CIK 0001380184 · Director · Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,748

Underlying: Common Stock · 25,748 shares

Expires 2031-05-22

F2 · derivative.exercise_date: Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price.

F3 · derivative.underlying_shares: The number of options granted was determined by dividing half of the total non-employee director compensation value by the Black-Scholes value of a single option calculated as of the date of the grant.

SEC source: 0001367644-24-000078 · wk-form4_1716945275.xml · nonDerivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director · Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,329

F1 · shares: Represents an annual grant of restricted stock units ("RSUs") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the "Company") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date ("Annual Grant Vesting Date"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date.

SEC source: 0001367644-24-000076 · wk-form4_1716945249.xml · derivative · entry 2

Richard Ronald · CIK 0001380177 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,748

Underlying: Common Stock · 25,748 shares

Expires 2031-05-22

F2 · derivative.exercise_date: Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price.

F3 · derivative.underlying_shares: The number of options granted was determined by dividing half of the total non-employee director compensation value by the Black-Scholes value of a single option calculated as of the date of the grant.

SEC source: 0001367644-24-000076 · wk-form4_1716945249.xml · nonDerivative · entry 1

Richard Ronald · CIK 0001380177 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,114

F1 · shares: Represents an annual grant of restricted stock units ("RSUs") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the "Company") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date ("Annual Grant Vesting Date"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date.

SEC source: 0001367644-24-000065 · wk-form4_1716498920.xml · nonDerivative · entry 1

Zoon Kathryn C · CIK 0001685720 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,882

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a grandfathered trading plan adopted by Ms. Zoon on June 15, 2022.

SEC source: 0001367644-24-000049 · wk-form4_1712705251.xml · nonDerivative · entry 1

Glessner Coleen · CIK 0001919170 · EVP, Quality & Ethics, and CPL

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 164,383

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-24-000048 · wk-form4_1712705240.xml · nonDerivative · entry 1

Hartzel William · CIK 0001989644 · SVP, Bioservices

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,274

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-24-000042 · wk-form4_1710537351.xml · derivative · entry 1

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 223,169

Underlying: Common Stock · 125,000 shares

Expires 2031-03-12

F1 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant.

SEC source: 0001367644-24-000045 · wk-form4_1710537389.xml · derivative · entry 1

PAPA JOSEPH C · CIK 0001242215 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 750,000

Underlying: Common Stock · 750,000 shares

Expires 2031-03-12

F1 · shares: Consists of 500,000 options to purchase shares granted under the Emergent BioSolutions Inc. Amended and Restated Stock Incentive Plan and 250,000 options to purchase shares granted under the Emergent BioSolutions Inc. Inducement Plan.

F2 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant.

SEC source: 0001367644-24-000041 · wk-form4_1710537332.xml · derivative · entry 1

LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 305,944

Underlying: Common Stock · 125,000 shares

Expires 2031-03-12

F1 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant.

SEC source: 0001367644-24-000043 · wk-form4_1710537364.xml · derivative · entry 1

Glessner Coleen · CIK 0001919170 · EVP, Quality & Ethics, and CPL

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 187,113

Underlying: Common Stock · 125,000 shares

Expires 2031-03-12

F1 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant.

SEC source: 0001367644-24-000044 · wk-form4_1710537376.xml · derivative · entry 1

Williams Paul Anthony · CIK 0001961994 · SVP, Products Business

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 147,614

Underlying: Common Stock · 125,000 shares

Expires 2031-03-12

F1 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant.

SEC source: 0001367644-24-000040 · wk-form4_1710537315.xml · derivative · entry 1

Hartzel William · CIK 0001989644 · SVP, Bioservices

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152,211

Underlying: Common Stock · 125,000 shares

Expires 2031-03-12

F1 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant.

SEC source: 0001367644-24-000029 · wk-form4_1709861499.xml · nonDerivative · entry 1

Hartzel William · CIK 0001989644 · SVP, Bioservices

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,939

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-24-000019 · wk-form4_1709595745.xml · nonDerivative · entry 2

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 173,758

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-24-000021 · wk-form4_1709595761.xml · nonDerivative · entry 2

LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 158,742

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-24-000024 · wk-form4_1709595782.xml · nonDerivative · entry 1

Glessner Coleen · CIK 0001919170 · EVP, Quality & Ethics, and CPL

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 164,968

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-24-000022 · wk-form4_1709595771.xml · nonDerivative · entry 2

Williams Paul Anthony · CIK 0001961994 · SVP, Products Business

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,882

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-24-000019 · wk-form4_1709595745.xml · nonDerivative · entry 1

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 174,461

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-24-000021 · wk-form4_1709595761.xml · nonDerivative · entry 1

LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 159,426

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-24-000022 · wk-form4_1709595771.xml · nonDerivative · entry 1

Williams Paul Anthony · CIK 0001961994 · SVP, Products Business

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,019

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-24-000010 · wk-form4_1709083709.xml · nonDerivative · entry 1

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 178,564

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-24-000008 · wk-form4_1709083590.xml · nonDerivative · entry 2

LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 168,463

F2 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-24-000012 · wk-form4_1709083811.xml · nonDerivative · entry 1

Williams Paul Anthony · CIK 0001961994 · SVP, Products Business

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,469

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-24-000008 · wk-form4_1709083590.xml · nonDerivative · entry 1

LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 168,980

F1 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA margin calculated on a cumulative basis over the three-year period beginning January 1, 2021 and ending December 31, 2023, as certified by the Compensation Committee following the performance period. On February 21, 2024, the final certification date, the Compensation Committee certified the achievement of the 2021-2023 PSUs at a payout factor of 0.00% of target resulting in the actual award of 0 shares of common stock, which is below the 4,012 shares previously reported on February 24, 2021.

SEC source: 0001367644-23-000190 · wk-form4_1700008050.xml · nonDerivative · entry 1

Williams Paul Anthony · CIK 0001961994 · SVP, Products Business

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,574

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-23-000191 · wk-form4_1700008089.xml · nonDerivative · entry 1

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 178,793

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-23-000189 · wk-form4_1700007995.xml · nonDerivative · entry 1

Hartzel William · CIK 0001989644 · SVP, Bioservices

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,285

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-23-000179 · wk-form4_1696547413.xml · nonDerivative · entry 1

Fowler Neal Franklin · CIK 0001493692 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,670

F1 · shares: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated. These restricted stock units will vest in three equal installments over a three-year period assuming continued service with the Company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

SEC source: 0001367644-23-000177 · wk-form4_1696547320.xml · nonDerivative · entry 1

DeGolyer Donald W · CIK 0001583098 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,670

F1 · shares: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated. These restricted stock units will vest in three equal installments over a three-year period assuming continued service with the Company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

SEC source: 0001367644-23-000139 · wk-form4_1690201790.xml · nonDerivative · entry 1

Williams Paul Anthony · CIK 0001961994 · SVP, Products Business

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,140

F1 · shares: Represents shares of common stock withheld to pay taxes.